Vasoprotection and nephroprotection: links of the same chain
Recently, the perception of microalbuminuria (MAU) has progressed from an indicator of renal artery dysfunction to a marker of systemic endothelial dysfunction, predicting cardiovascular risk. MAU is also a significant marker of vascular pathology, including renal, peripheral, cerebral vessels and a...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1653 |
| id |
doaj-c9f1d6c5d9174a588f6a39b2189ed0ee |
|---|---|
| record_format |
Article |
| spelling |
doaj-c9f1d6c5d9174a588f6a39b2189ed0ee2021-07-28T13:50:37Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01251970-01-01871141201371Vasoprotection and nephroprotection: links of the same chainN. Sh. Zagidullin0Sh. Z. Zagidullin1K. F. Valeeva2Bashkir State Medical UniversityBashkir State Medical UniversityBashkir State Medical UniversityRecently, the perception of microalbuminuria (MAU) has progressed from an indicator of renal artery dysfunction to a marker of systemic endothelial dysfunction, predicting cardiovascular risk. MAU is also a significant marker of vascular pathology, including renal, peripheral, cerebral vessels and aorta. Therefore, primary and secondary MAU prevention with angiotensin II inhibition (often as a part of combined therapy) is one of the main goals in nephro-, cardioand vasoprotection.https://cardiovascular.elpub.ru/jour/article/view/1653endothelial dysfunctionmicroalbuminurianephroprotectionvasoprotection |
| collection |
DOAJ |
| language |
Russian |
| format |
Article |
| sources |
DOAJ |
| author |
N. Sh. Zagidullin Sh. Z. Zagidullin K. F. Valeeva |
| spellingShingle |
N. Sh. Zagidullin Sh. Z. Zagidullin K. F. Valeeva Vasoprotection and nephroprotection: links of the same chain Кардиоваскулярная терапия и профилактика endothelial dysfunction microalbuminuria nephroprotection vasoprotection |
| author_facet |
N. Sh. Zagidullin Sh. Z. Zagidullin K. F. Valeeva |
| author_sort |
N. Sh. Zagidullin |
| title |
Vasoprotection and nephroprotection: links of the same chain |
| title_short |
Vasoprotection and nephroprotection: links of the same chain |
| title_full |
Vasoprotection and nephroprotection: links of the same chain |
| title_fullStr |
Vasoprotection and nephroprotection: links of the same chain |
| title_full_unstemmed |
Vasoprotection and nephroprotection: links of the same chain |
| title_sort |
vasoprotection and nephroprotection: links of the same chain |
| publisher |
«SILICEA-POLIGRAF» LLC |
| series |
Кардиоваскулярная терапия и профилактика |
| issn |
1728-8800 2619-0125 |
| publishDate |
1970-01-01 |
| description |
Recently, the perception of microalbuminuria (MAU) has progressed from an indicator of renal artery dysfunction to a marker of systemic endothelial dysfunction, predicting cardiovascular risk. MAU is also a significant marker of vascular pathology, including renal, peripheral, cerebral vessels and aorta. Therefore, primary and secondary MAU prevention with angiotensin II inhibition (often as a part of combined therapy) is one of the main goals in nephro-, cardioand vasoprotection. |
| topic |
endothelial dysfunction microalbuminuria nephroprotection vasoprotection |
| url |
https://cardiovascular.elpub.ru/jour/article/view/1653 |
| work_keys_str_mv |
AT nshzagidullin vasoprotectionandnephroprotectionlinksofthesamechain AT shzzagidullin vasoprotectionandnephroprotectionlinksofthesamechain AT kfvaleeva vasoprotectionandnephroprotectionlinksofthesamechain |
| _version_ |
1721271602397577216 |